BioSpace News Archive

Safety Profile Consistent with Previously Published Phase 2 Data for Mitapivat in Patients with Pyruvate Kinase Deficiency or Expected in the Context of Sickle Cell Disease

Aprea Therapeutics, Inc., a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53, announced the oral presentation of updated data from its French Phase 1b/2 clinical trial at the 25th European Hematology Association Annual Meeting.

Centene Corporation announced on June 12, 2020 its updated 2020 financial guidance. Total revenues are expected to be $109.5 billion to $111.9 billion, and diluted earnings per share are expected to be $3.06 to $3.20.

Newsight Imaging, the CMOS image sensor chip maker for 3D machine vision and spectral analysis applications announced the release of its SpectraLIT™, a compact development kit suitable for testing Newsight technology and developing proof-of-concept devices for the healthcare and food & beverage industries or other liquids analysis.

Positive Phase 3 Data Evaluating NINLARO as a Maintenance Therapy (TOURMALINE-MM4) Shows Significant Improvement in Progression-Free Survival in Adult Patients Not Treated with Stem Cell Transplantation − Real-World Community-Based Trial (US MM-6) Results Show Deepening of Responses and Favorable Safety Profile in Transition from Parenteral Bortezomib to Oral NINLARO-Based Treatment − Oral Presentations Among 12 Takeda-Sponsored Abstract

Transparency Market Research has published a new report titled, “Cardiac Ablation Technologies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

Transparency Market Research has published a new report titled, “Anticoagulant Reversal Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.